About ASKA Biotech
ASKA Biotech provides monoclonal antibodies and recombinant proteins in constant high-quality. Our products are used for research, in-vitro diagnostic and preclinical trials. We support our customers for their success. Our goal is to provide independent reliable services at competitive prices, to fulfill the specific requirements of our customers. Each member of our team is well-trained in his field of activity, with multiple years of experience. ASKA Biotech will be your first choice independent partner for your outsourcing needs. Next to our ISO 9001:2015 certification we will be certified for ISO 13485 and will launch medical devices. With satisfied customers all over the world, we name small research units, small and medium sized enterprises and global pharmaceutical companies to our clients. Moreover we have a deep focus on digital transformation to connect order processing with our production processes. So we are able to offer you the whole value chain on our future online platform.
- Focus : Service
- Industry : Biotechnology
Product portfolio of ASKA Biotech
Here you will find ASKA Biotech GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
